RICHARD A. KRUMHOLZ, M.D.; FELICE MANFREDI, M.D.; JOHN G. WEG; DAVID ROSENBAUM, M.D.
Aspiration needle biopsy of the lung has been known in the English literature since 1909 (1). It was subsequently shown to have definite value as a diagnostic tool in septic conditions involving the lung and in pulmonary neoplastic disease (2-18). Percutaneous lung biopsy with a cutting type biopsy needle (Vim-Silverman) was first described in 1959 (19). Since that time, eight other reports on the use of this type of needle have been published (20-27). In the past 5 years we have performed 126 percutaneous needle lung biopsies in 112 patients with diffuse pulmonary disease. Since diffuse pulmonary parenchymal disease usually
KRUMHOLZ RA, MANFREDI F, WEG JG, et al. Needle Biopsy of the Lung: Report on its Use in 112 Patients and Review of the Literature. Ann Intern Med. 1966;65:293–307. doi: https://doi.org/10.7326/0003-4819-65-2-293
Download citation file:
© 2020
Published: Ann Intern Med. 1966;65(2):293-307.
DOI: 10.7326/0003-4819-65-2-293
Pulmonary/Critical Care.
Results provided by: